Nath Bio-Genes (India) Limited — Others, 23-10-2024: Change in Management

Nath Bio-Genes (India) Limited has approved unaudited standalone and consolidated financial results for the half-year ending September 30, 2024. The company reported a standalone net profit of ₹3677.61 lakhs. Additionally, there were key management changes: Devinder Khurana relinquished his role as Chief Financial Officer, effective October 23, 2024, and Amol Gupta has been promoted to CFO. Financial documents and annexures detailing these updates are available on the company’s website.